All In MedTech

FDA Clearance Tracker · P030006-S022

PROLIEVE THERMODILITATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 23, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 23, 2009

Approved

Time to decision

235 days

Received Apr 2, 2009. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030006-S022
Device name
PROLIEVE THERMODILITATION SYSTEM
Applicant location
Columbia, MD
Received
Apr 2, 2009
Decided
Nov 23, 2009
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030006

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR SPECIFIC MODIFICATIONS TO THE TREATMENT CATHETER DESIGN, CATHETER MANUFACTURING PROCESSES, AND CATHETER SPECIFICATIONS.

Source documents

Other decisions for Medifocus, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.